3a,4,5,6,7,7a-Hexahydromethoxydimethyl-4,7-methano-1H-indene
Common Name: |
3a,4,5,6,7,7a-Hexahydromethoxydimethyl-4,7-methano-1H-indene |
IUPAC Name: |
3-methoxy-4,5-dimethyltricyclo[5.2.1.02,6]dec-3-ene |
Molecular Formula: |
C13H20O |
SMILES: |
CC1C2C3CCC(C3)C2C(=C1C)OC |
Inchi: |
1S/C13H20O/c1-7-8(2)13(14-3)12-10-5-4-9(6-10)11(7)12/h7,9-12H,4-6H2,1-3H3 |
Inchi Key: |
VOJLZMSJAQIWCN-UHFFFAOYSA-N |
Cas No: |
93942-00-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
192.30 |
Mass (g/mol) |
192.151 |
Molar Refractivity |
60.10 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
2 |
Rings |
3 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
249.09 |
Vapor Pressure (mmHg@25.00 °C) |
0.037 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.77 |
LogP |
3.219 |
iLOGP |
2.54 |
XLOGP3 |
2.61 |
WLOGP |
3.06 |
MLOGP |
3.04 |
ESOL Log S |
-2.54 |
ESOL Solubility (mg/ml) |
0.549 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.62 |
Ali Solubility (mg/ml) |
0.46 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.09 |
Silicos-IT Solubility (mg/ml) |
1.57 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.62 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.49 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3.099 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |